Alvotech (ALVO) Net Cash Flow (2021 - 2026)
Alvotech (ALVO) posted Net Cash Flow of -$107.6 million for Q1 2026, down 123.4% on a QoQ basis from $459.8 million in Q4 2025, and down 686.2% year-over-year from $18.4 million in Q1 2025.
Alvotech (ALVO) Net Cash Flow (2021 - 2026) Analysis & Trends
Alvotech's Net Cash Flow history runs 6 years deep, the most recent figure standing at -$107.6 million for Q1 2026.
- Quarterly Net Cash Flow fell 686.2% year-over-year to -$107.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.9 million (up 137.7% YoY) and the FY2025 annual result came in at $173.8 million, up 317.75% from the prior year.
- Net Cash Flow was -$107.6 million for Q1 2026 at Alvotech, down from $459.8 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $459.8 million in Q4 2025 and bottomed at -$382.6 million in Q3 2025.
- A 5-year average of -$62.8 million and a median of -$53.7 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2025 — Net Cash Flow soared 1013.24% — and 2026, when it slumped 686.2%.
- Alvotech's Net Cash Flow stood at -$375.9 million in 2022, then gained by 10.12% to -$337.9 million in 2023, then surged by 112.22% to $41.3 million in 2024, then surged by 1013.24% to $459.8 million in 2025, then sank by 123.4% to -$107.6 million in 2026.
- Business Quant data shows ALVO's Net Cash Flow at -$107.6 million in Q1 2026, $459.8 million in Q4 2025, and -$382.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | -277.40 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.60 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.49 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Alvotech | 924.10 Mn | 924.10 Mn | 5.09 Mn | -107.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -107.59 Mn |
| Mar 31, 2026 | -107.59 Mn |
| Dec 31, 2025 | 459.79 Mn |
| Dec 31, 2025 | 459.79 Mn |
| Sep 30, 2025 | -382.63 Mn |
| Sep 30, 2025 | -382.63 Mn |
| Jun 30, 2025 | 110.29 Mn |
| Jun 30, 2025 | 110.29 Mn |
| Mar 31, 2025 | -13.69 Mn |
| Mar 31, 2025 | -13.69 Mn |
| Dec 31, 2024 | 41.30 Mn |
| Dec 31, 2024 | 41.30 Mn |
| Sep 30, 2024 | -185.78 Mn |
| Sep 30, 2024 | -185.78 Mn |
| Jun 30, 2024 | -53.68 Mn |
| Jun 30, 2024 | -53.68 Mn |
| Mar 31, 2024 | 54.30 Mn |
| Mar 31, 2024 | 54.30 Mn |
| Dec 31, 2023 | -337.86 Mn |
| Dec 31, 2023 | -337.86 Mn |